Figure 3.
Figure 3. The effect of kinase inhibitors on platelet aggregation caused by the simultaneous stimulation of Gi and Gz or Gq and Gi pathways. Platelets were preincubated with kinase inhibitors as follows: 10 minutes at 37°C with dimethyl sulfoxide (DMSO) (vehicle), 3 minutes at 37°C with 10 μM Ro 31-8220, 10 minutes of preincubation at 37°C with 1 μM dimethyl BAPTA-AM, or 10 minutes of preincubation with 25 μM LY294002. Platelets were stimulated with 100 nM 2-MeSADP, 10 μM epinephrine, or a combination of both agonists, as noted, for Gi and Gz stimulation. MRS2179 (100 μM) was added 1 minute prior to platelet stimulation. ADP (10 μM) was used as an agonist for stimulation of Gq and Gi pathways. All aggregation tracings were performed in the presence of 1 mg/mL fibrinogen. Tracings are representative of results obtained from 3 donors and 3 separate experiments.

The effect of kinase inhibitors on platelet aggregation caused by the simultaneous stimulation of Gi and Gz or Gq and Gi pathways. Platelets were preincubated with kinase inhibitors as follows: 10 minutes at 37°C with dimethyl sulfoxide (DMSO) (vehicle), 3 minutes at 37°C with 10 μM Ro 31-8220, 10 minutes of preincubation at 37°C with 1 μM dimethyl BAPTA-AM, or 10 minutes of preincubation with 25 μM LY294002. Platelets were stimulated with 100 nM 2-MeSADP, 10 μM epinephrine, or a combination of both agonists, as noted, for Gi and Gz stimulation. MRS2179 (100 μM) was added 1 minute prior to platelet stimulation. ADP (10 μM) was used as an agonist for stimulation of Gq and Gi pathways. All aggregation tracings were performed in the presence of 1 mg/mL fibrinogen. Tracings are representative of results obtained from 3 donors and 3 separate experiments.

Close Modal

or Create an Account

Close Modal
Close Modal